{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T04:11:20Z","timestamp":1748578280644,"version":"3.41.0"},"edition-number":"1","reference-count":109,"publisher":"European Respiratory Society","isbn-type":[{"type":"print","value":"9781849840613"},{"type":"electronic","value":"9781849840620"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1183\/2312508x.10009414","type":"book-chapter","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T19:23:45Z","timestamp":1438889025000},"source":"Crossref","is-referenced-by-count":0,"title":["Idiopathic pulmonary fibrosis"],"prefix":"10.1183","author":[{"given":"Carlos Robalo","family":"Cordeiro","sequence":"first","affiliation":[]},{"given":"Tiago M.","family":"Alfaro","sequence":"additional","affiliation":[]},{"given":"Sara","family":"Freitas","sequence":"additional","affiliation":[]},{"given":"Jessica","family":"Cemlyn-Jones","sequence":"additional","affiliation":[]}],"member":"81","reference":[{"key":"2015080611583141000_9781849840620.1.chapter_5.1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1164\/ajrccm\/138.3.703","article-title":"Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs","volume":"138","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"2015080611583141000_9781849840620.1.chapter_5.2","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1165\/ajrcmb.22.5.3948","article-title":"Different expression of TNF-alpha receptors and prostaglandin E(2) production in normal and fibrotic lung fibroblasts: potential implications for the evolution of the inflammatory process","volume":"22","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1042\/bj3210639","article-title":"Indomethacin suppresses the anti-proliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures","volume":"321","year":"1997","journal-title":"Biochem J"},{"key":"2015080611583141000_9781849840620.1.chapter_5.4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1513\/pats.200601-001TK","article-title":"Evolving concepts of apoptosis in idiopathic pulmonary fibrosis","volume":"3","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"2015080611583141000_9781849840620.1.chapter_5.5","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1164\/rccm.200802-313OC","article-title":"Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis","volume":"178","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1378\/chest.127.1.266","article-title":"Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis","volume":"127","year":"2005","journal-title":"Chest"},{"key":"2015080611583141000_9781849840620.1.chapter_5.7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/jcp.54.2.132","article-title":"Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)\/usual interstitial pneumonia (UIP)","volume":"54","year":"2001","journal-title":"J Clin Pathol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1183\/09059180.00001012","article-title":"Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis","volume":"21","year":"2012","journal-title":"Eur Respir Rev"},{"key":"2015080611583141000_9781849840620.1.chapter_5.9","first-page":"L1192","article-title":"Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung","volume":"275","year":"1998","journal-title":"Am J Physiol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/path.1208","article-title":"MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis","volume":"198","year":"2002","journal-title":"J Pathol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1183\/09031936.02.00252602","article-title":"Resistance to Fas-mediated apoptosis in human lung fibroblast","volume":"20","year":"2002","journal-title":"Eur Respir J"},{"key":"2015080611583141000_9781849840620.1.chapter_5.12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1465-9921-6-37","article-title":"Altered expression of membrane-bound and soluble CD95\/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis","volume":"6","year":"2005","journal-title":"Respir Res"},{"key":"2015080611583141000_9781849840620.1.chapter_5.13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1465-9921-6-141","article-title":"TGF-beta1 and serum both stimulate contraction but differentially affect apoptosis in 3D collagen gels","volume":"6","year":"2005","journal-title":"Respir Res"},{"key":"2015080611583141000_9781849840620.1.chapter_5.14","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1164\/ajrccm.161.4.9908012","article-title":"Molecular and genetic aspects of lung cancer","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1440-1827.1999.00888.x","article-title":"K-ras gene point mutation in neogenetic lesions of subpleural fibrotic lesions: either an early genetic event in lung cancer development or a non-specific genetic change during the inflammatory reparative process","volume":"49","year":"1999","journal-title":"Pathol Int"},{"key":"2015080611583141000_9781849840620.1.chapter_5.16","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1183\/09031936.98.12061404","article-title":"Heterogeneous point mutations of the p53 gene in pulmonary fibrosis","volume":"12","year":"1998","journal-title":"Eur Respir J"},{"key":"2015080611583141000_9781849840620.1.chapter_5.17","first-page":"8527","article-title":"Aberrations in the fragile histidine triad (FHIT) gene in idiopathic pulmonary fibrosis","volume":"61","year":"2001","journal-title":"Cancer Res"},{"key":"2015080611583141000_9781849840620.1.chapter_5.18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1582-4934.2002.tb00188.x","article-title":"MYCL1, FHIT, SPARC, p16(INK4) and TP53 genes associated to lung cancer in idiopathic pulmonary fibrosis","volume":"6","year":"2002","journal-title":"J Cell Mol Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12931-014-0094-1","article-title":"Smoking accelerates aging of the small airway epithelium","volume":"15","year":"2014","journal-title":"Respir Res"},{"key":"2015080611583141000_9781849840620.1.chapter_5.20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.trsl.2013.04.001","article-title":"Telomeres in lung disease","volume":"162","year":"2013","journal-title":"Transl Res"},{"key":"2015080611583141000_9781849840620.1.chapter_5.21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1164\/rccm.200804-550OC","article-title":"Telomere shortening in familial and sporadic pulmonary fibrosis","volume":"178","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.22","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/JTO.0b013e3181886713","article-title":"Telomeres and telomerase in lung cancer","volume":"3","year":"2008","journal-title":"J Thorac Oncol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4161\/epi.6.7.16262","article-title":"Epigenetic mechanisms and cancer: an interface between the environment and the genome","volume":"6","year":"2011","journal-title":"Epigenetics"},{"key":"2015080611583141000_9781849840620.1.chapter_5.24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1165\/rcmb.2007-0322OC","article-title":"Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis","volume":"39","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.25","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.1038\/cddis.2013.146","article-title":"Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts","volume":"4","year":"2013","journal-title":"Cell Death Dis"},{"key":"2015080611583141000_9781849840620.1.chapter_5.26","doi-asserted-by":"crossref","first-page":"L295","DOI":"10.1152\/ajplung.00332.2011","article-title":"Hypermethylation-mediated silencing of p14(ARF) in fibroblasts from idiopathic pulmonary fibrosis","volume":"303","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.27","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.bjc.6605901","article-title":"MicroRNA in lung cancer","volume":"103","year":"2010","journal-title":"Br J Cancer"},{"key":"2015080611583141000_9781849840620.1.chapter_5.28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.trsl.2011.01.012","article-title":"MicroRNAs in idiopathic pulmonary fibrosis","volume":"157","year":"2011","journal-title":"Transl Res"},{"key":"2015080611583141000_9781849840620.1.chapter_5.29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ajpath.2011.10.005","article-title":"Participation of miR-200 in pulmonary fibrosis","volume":"180","year":"2012","journal-title":"Am J Pathol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1164\/rccm.200911-1698OC","article-title":"Inhibition and role of let-7d in idiopathic pulmonary fibrosis","volume":"182","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5301\/JBM.2010.6115","article-title":"Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis","volume":"25","year":"2010","journal-title":"Int J Biol Markers"},{"key":"2015080611583141000_9781849840620.1.chapter_5.32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.lungcan.2009.11.009","article-title":"Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: a meta-analysis","volume":"69","year":"2010","journal-title":"Lung Cancer"},{"key":"2015080611583141000_9781849840620.1.chapter_5.33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2004.08.040","article-title":"Wnt signaling in lung cancer","volume":"222","year":"2005","journal-title":"Cancer Lett"},{"key":"2015080611583141000_9781849840620.1.chapter_5.34","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/beta-catenin signaling and disease","volume":"149","year":"2012","journal-title":"Cell"},{"key":"2015080611583141000_9781849840620.1.chapter_5.35","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0002-9440(10)64282-4","article-title":"Aberrant Wnt\/beta-catenin pathway activation in idiopathic pulmonary fibrosis","volume":"162","year":"2003","journal-title":"Am J Pathol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.36","doi-asserted-by":"crossref","first-page":"e2142","DOI":"10.1371\/journal.pone.0002142","article-title":"Functional Wnt signaling is increased in idiopathic pulmonary fibrosis","volume":"3","year":"2008","journal-title":"PLoS One"},{"key":"2015080611583141000_9781849840620.1.chapter_5.37","doi-asserted-by":"crossref","first-page":"e24663","DOI":"10.1371\/journal.pone.0024663","article-title":"Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms","volume":"6","year":"2011","journal-title":"PLoS One"},{"key":"2015080611583141000_9781849840620.1.chapter_5.38","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.tranon.2014.05.002","article-title":"Activation of oncogenic pathways in idiopathic pulmonary fibrosis","volume":"7","year":"2014","journal-title":"Transl Oncol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.39","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrc2841","article-title":"Implications and challenges of connexin connections to cancer","volume":"10","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"2015080611583141000_9781849840620.1.chapter_5.40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1465-9921-7-122","article-title":"Altered intercellular communication in lung fibroblast cultures from patients with idiopathic pulmonary fibrosis","volume":"7","year":"2006","journal-title":"Respir Res"},{"key":"2015080611583141000_9781849840620.1.chapter_5.41","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbamem.2005.08.012","article-title":"Connexins as targets for cancer chemoprevention and chemotherapy","volume":"1719","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"2015080611583141000_9781849840620.1.chapter_5.42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/carcin\/19.1.61","article-title":"Frequent reduction of gap junctional intercellular communication and connexin43 expression in human and mouse lung carcinoma cells","volume":"19","year":"1998","journal-title":"Carcinogenesis"},{"key":"2015080611583141000_9781849840620.1.chapter_5.43","doi-asserted-by":"crossref","first-page":"13682","DOI":"10.1074\/jbc.M407762200","article-title":"Oxidative activation of protein kinase Cgamma through the C1 domain. Effects on gap junctions","volume":"280","year":"2005","journal-title":"J Biol Chem"},{"key":"2015080611583141000_9781849840620.1.chapter_5.44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1432-0436.2006.00133.x","article-title":"Connexin43 repression following epithelium-to-mesenchyme transition in embryonal carcinoma cells requires Snail1 transcription factor","volume":"75","year":"2007","journal-title":"Differentiation"},{"key":"2015080611583141000_9781849840620.1.chapter_5.45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/ars.2008.2183","article-title":"Cross-talk between pulmonary injury, oxidant stress, and gap junctional communication","volume":"11","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"2015080611583141000_9781849840620.1.chapter_5.46","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/carcin\/19.11.1889","article-title":"Suppression of tumorigenicity of human lung carcinoma cells after transfection with connexin43","volume":"19","year":"1998","journal-title":"Carcinogenesis"},{"key":"2015080611583141000_9781849840620.1.chapter_5.47","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2015080611583141000_9781849840620.1.chapter_5.48","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression","volume":"432","year":"2004","journal-title":"Nature"},{"key":"2015080611583141000_9781849840620.1.chapter_5.49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.molmed.2013.05.004","article-title":"\u2018Cancer associated fibroblasts\u2019 \u2013 more than meets the eye","volume":"19","year":"2013","journal-title":"Trends Mol Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.semcancer.2013.12.008","article-title":"TGF-beta in CAF-mediated tumor growth and metastasis","volume":"25","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.51","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/jclinpath-2014-202561","article-title":"Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology","volume":"67","year":"2014","journal-title":"J Clin Pathol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.52","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","year":"2011","journal-title":"Lancet"},{"key":"2015080611583141000_9781849840620.1.chapter_5.53","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1164\/rccm.200602-205OC","article-title":"Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum","volume":"174","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.54","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"2015080611583141000_9781849840620.1.chapter_5.55","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/thoraxjnl-2013-204608","article-title":"Epithelial-mesenchymal transition in lung development and disease: does it exist and is it important?","volume":"69","year":"2014","journal-title":"Thorax"},{"key":"2015080611583141000_9781849840620.1.chapter_5.56","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1465-9921-7-95","article-title":"Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis","volume":"7","year":"2006","journal-title":"Respir Res"},{"key":"2015080611583141000_9781849840620.1.chapter_5.57","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2220\/biomedres.33.309","article-title":"Laminin-5gamma2 chain expression is associated with tumor cell invasiveness and prognosis of lung squamous cell carcinoma","volume":"33","year":"2012","journal-title":"Biomed Res"},{"key":"2015080611583141000_9781849840620.1.chapter_5.58","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cub.2009.12.035","article-title":"The actin-bundling protein fascin stabilizes actin in invadopodia and potentiates protrusive invasion","volume":"20","year":"2010","journal-title":"Curr Biol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.59","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/ijc.28464","article-title":"HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor","volume":"134","year":"2014","journal-title":"Int J Cancer"},{"key":"2015080611583141000_9781849840620.1.chapter_5.60","first-page":"559","article-title":"The association of terminal bronchiolar carcinoma with chronic interstitial inflammation and fibrosis of the lungs","volume":"76","year":"1957","journal-title":"Am Rev Tuberc"},{"key":"2015080611583141000_9781849840620.1.chapter_5.61","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00007611-199605000-00012","article-title":"Pulmonary fibrosis and lung cancer in the United States: analysis of the multiple cause of death mortality data, 1979 through 1991","volume":"89","year":"1996","journal-title":"South Med J"},{"key":"2015080611583141000_9781849840620.1.chapter_5.62","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1440-1827.1995.tb03417.x","article-title":"Lung cancer associated with usual interstitial pneumonia","volume":"45","year":"1995","journal-title":"Pathol Int"},{"key":"2015080611583141000_9781849840620.1.chapter_5.63","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4065\/77.8.763","article-title":"Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis","volume":"77","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"2015080611583141000_9781849840620.1.chapter_5.64","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1183\/09031936.01.99055301","article-title":"Lung cancer in patients with idiopathic pulmonary fibrosis","volume":"17","year":"2001","journal-title":"Eur Respir J"},{"key":"2015080611583141000_9781849840620.1.chapter_5.65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1164\/ajrccm.161.1.9906062","article-title":"Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.66","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/j.rmed.2007.07.012","article-title":"The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK","volume":"101","year":"2007","journal-title":"Respir Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.67","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1440-1843.2009.01547.x","article-title":"Cumulative incidence of and predictive factors for lung cancer in IPF","volume":"14","year":"2009","journal-title":"Respirology"},{"key":"2015080611583141000_9781849840620.1.chapter_5.68","doi-asserted-by":"crossref","first-page":"A195","DOI":"10.1136\/thoraxjnl-2014-206260.395","article-title":"P277 The incidence of lung cancer in people with idiopathic pulmonary fibrosis and connective tissue disease associated pulmonary fibrosis in the UK: a population based study","volume":"69","year":"2014","journal-title":"Thorax"},{"key":"2015080611583141000_9781849840620.1.chapter_5.69","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.rmed.2013.11.013","article-title":"Lung cancer risk among patients with combined pulmonary fibrosis and emphysema","volume":"108","year":"2014","journal-title":"Respir Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.70","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1759-7714.2011.00107.x","article-title":"Prevalence, risk factors and survival of lung cancer in the idiopathic pulmonary fibrosis","volume":"3","year":"2012","journal-title":"Thorac Cancer"},{"key":"2015080611583141000_9781849840620.1.chapter_5.71","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00063198-200109000-00005","article-title":"Idiopathic pulmonary fibrosis and malignancy","volume":"7","year":"2001","journal-title":"Curr Opin Pulm Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.72","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/JTO.0000000000000209","article-title":"Lung cancer in combined pulmonary fibrosis and emphysema: a series of 47 Western patients","volume":"9","year":"2014","journal-title":"J Thorac Oncol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.73","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.74","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1378\/chest.121.4.1278","article-title":"Association of malignancy with diseases causing interstitial pulmonary changes","volume":"121","year":"2002","journal-title":"Chest"},{"key":"2015080611583141000_9781849840620.1.chapter_5.75","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2214\/AJR.11.7516","article-title":"Lung cancer in chronic interstitial pneumonia: early manifestation from serial CT observations","volume":"199","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.76","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.rmed.2014.07.020","article-title":"Lung cancer in patients with idiopathic pulmonary fibrosis: clinical characteristics and impact on survival","volume":"108","year":"2014","journal-title":"Respir Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.77","first-page":"266","article-title":"Treatment and outcome of lung cancer in idiopathic interstitial pneumonias","volume":"31","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2015080611583141000_9781849840620.1.chapter_5.78","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1378\/chest.108.5.1272","article-title":"Clinical characteristics of synchronous multiple lung cancer associated with idiopathic pulmonary fibrosis. A review of Japanese cases","volume":"108","year":"1995","journal-title":"Chest"},{"key":"2015080611583141000_9781849840620.1.chapter_5.79","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1620\/tjem.167.231","article-title":"Lung cancer in patients with idiopathic pulmonary fibrosis","volume":"167","year":"1992","journal-title":"Tohoku J Exp Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.80","first-page":"11","article-title":"Diffuse interstitial pulmonary fibrosis and lung cancer","volume":"37","year":"1987","journal-title":"Acta Pathol Jpn"},{"key":"2015080611583141000_9781849840620.1.chapter_5.81","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/1097-0142(197305)31:5<1078::AID-CNCR2820310507>3.0.CO;2-1","article-title":"Carcinoma and diffuse interstitial fibrosis of lung","volume":"31","year":"1973","journal-title":"Cancer"},{"key":"2015080611583141000_9781849840620.1.chapter_5.82","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.lungcan.2014.05.016","article-title":"Clinical features, anti-cancer treatments and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema","volume":"85","year":"2014","journal-title":"Lung Cancer"},{"key":"2015080611583141000_9781849840620.1.chapter_5.83","first-page":"435","article-title":"Multiple primary bronchogenic carcinoma with a review of the literature","volume":"109","year":"1974","journal-title":"Am Rev Respir Dis"},{"year":"2013","author":"National Clinical Guideline C","key":"2015080611583141000_9781849840620.1.chapter_5.84"},{"key":"2015080611583141000_9781849840620.1.chapter_5.85","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","year":"2014","journal-title":"N Engl J Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.86","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","year":"2014","journal-title":"N Engl J Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.87","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jso.10145","article-title":"Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis","volume":"81","year":"2002","journal-title":"J Surg Oncol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.88","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1055\/s-2007-965645","article-title":"Operative indications for lung cancer with idiopathic pulmonary fibrosis","volume":"55","year":"2007","journal-title":"Thorac Cardiovasc Surg"},{"key":"2015080611583141000_9781849840620.1.chapter_5.89","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1378\/chest.07-0299","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis","volume":"132","year":"2007","journal-title":"Chest"},{"key":"2015080611583141000_9781849840620.1.chapter_5.90","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00595-010-4384-z","article-title":"Risk of acute exacerbation of interstitial pneumonia after pulmonary resection for lung cancer in patients with idiopathic pulmonary fibrosis based on preoperative high-resolution computed tomography","volume":"41","year":"2011","journal-title":"Surg Today"},{"key":"2015080611583141000_9781849840620.1.chapter_5.91","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0022-5223(03)00028-X","article-title":"Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection","volume":"125","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2015080611583141000_9781849840620.1.chapter_5.92","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11748-009-0569-z","article-title":"Predictive factors for postoperative acute exacerbation of interstitial pneumonia combined with lung cancer","volume":"58","year":"2010","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2015080611583141000_9781849840620.1.chapter_5.93","first-page":"960316","article-title":"Postoperative acute exacerbation of IPF after lung resection for primary lung cancer","volume":"2011","year":"2011","journal-title":"Pulm Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.94","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s10147-013-0566-1","article-title":"Idiopathic pulmonary fibrosis as a prognostic factor in non-small cell lung cancer","volume":"19","year":"2014","journal-title":"Int J Clin Oncol"},{"year":"2014","journal-title":"Surg Today","article-title":"Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis","key":"2015080611583141000_9781849840620.1.chapter_5.95"},{"key":"2015080611583141000_9781849840620.1.chapter_5.96","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.lungcan.2010.04.014","article-title":"The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias","volume":"71","year":"2011","journal-title":"Lung Cancer"},{"key":"2015080611583141000_9781849840620.1.chapter_5.97","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10147-013-0554-5","article-title":"Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis","volume":"19","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.98","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000342046","article-title":"Efficacy of chemotherapy for advanced non-small cell lung cancer with idiopathic pulmonary fibrosis","volume":"85","year":"2013","journal-title":"Respiration"},{"key":"2015080611583141000_9781849840620.1.chapter_5.99","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2169\/internalmedicine.48.1650","article-title":"Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy","volume":"48","year":"2009","journal-title":"Intern Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1470-2045(13)70586-2","article-title":"Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial","volume":"15","year":"2014","journal-title":"Lancet Oncol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.101","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1378\/chest.14-0359","article-title":"The impact of lung cancer on survival of idiopathic pulmonary fibrosis","volume":"147","year":"2015","journal-title":"Chest"},{"key":"2015080611583141000_9781849840620.1.chapter_5.102","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0022-3565(24)35110-9","article-title":"Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis","volume":"291","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"2015080611583141000_9781849840620.1.chapter_5.103","first-page":"254","article-title":"Prevention of bleomycin-induced lung injury in rats by keratinocyte growth factor","volume":"109","year":"1997","journal-title":"Proc Assoc Am Physicians"},{"key":"2015080611583141000_9781849840620.1.chapter_5.104","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1164\/ajrccm.162.6.9908097","article-title":"Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis","volume":"162","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1164\/rccm.201205-0888OC","article-title":"Epigenetic regulation of miR-17\u223c92 contributes to the pathogenesis of pulmonary fibrosis","volume":"187","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.106","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/mt.2012.36","article-title":"miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice","volume":"20","year":"2012","journal-title":"Mol Ther"},{"key":"2015080611583141000_9781849840620.1.chapter_5.107","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1620\/tjem.223.45","article-title":"Blockade of the wnt\/beta-catenin pathway attenuates bleomycin-induced pulmonary fibrosis","volume":"223","year":"2011","journal-title":"Tohoku J Exp Med"},{"key":"2015080611583141000_9781849840620.1.chapter_5.108","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.ajpath.2011.02.045","article-title":"Spontaneous lung dysfunction and fibrosis in mice lacking connexin 40 and endothelial cell connexin 43","volume":"178","year":"2011","journal-title":"Am J Pathol"},{"key":"2015080611583141000_9781849840620.1.chapter_5.109","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1084\/jem.20102510","article-title":"Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44","volume":"208","year":"2011","journal-title":"J Exp Med"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/2312508X.10009414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T22:20:59Z","timestamp":1748557259000},"score":1,"resource":{"primary":{"URL":"http:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/2312508X.10009414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"ISBN":["9781849840613","9781849840620"],"references-count":109,"alternative-id":["10.1183\/2312508X.erm6815"],"URL":"https:\/\/doi.org\/10.1183\/2312508x.10009414","relation":{},"subject":[],"published":{"date-parts":[[2015,6]]}}}